Based on an analysis of the shareholder structure at the end of 2017, we were able to match around 87% (2016: 93%) of the approximately 306.5 M shares outstanding with their owners. As of December 31, 2017, the number of Fresenius Medical Care shares held by our largest shareholder, Fresenius SE & Co. KGaA, remained unchanged at around 94.4 M. This corresponds to 30.6% of the ordinary shares in our share capital. In the same analysis, we identified a further 13 institutional investors with shareholdings of more than 1%.
According to the analysis, 638 institutional investors (2016: 525) own Fresenius Medical Care shares, with the top 20 investors alone holding approximately 43% of identified shares in the free float 2016: 40%).
Regarding the distribution of regionally attributable shares owned by institutional investors, 36% of the shares in the free float were held in Great Britain. With around 8% each of all shares identified in the free float were held in Germany and France, 4% in Norway. The shares held in North America remained stable at 28%.
Number of identified shares
Number of shares
Number of shares outstanding as of December 31, 2017
Shares in free float
Geographical distribution of identified shares
Notification of voting rights
Due to legal requirements, the total number of voting rights is calculated on the basis of all shares and does not consider the share buy-back program.